Recap: ADMA Biologics Q1 Earnings

ADMA Biologics ADMA reported its Q1 earnings results on Wednesday, May 10, 2023 at 04:05 PM.

Here's what investors need to know about the announcement.

ADMA Biologics beat estimated earnings by 25.0%, reporting an EPS of $-0.03 versus an estimate of $-0.04.

Revenue was up $27.81 million from the same period last year.

Last quarter the company missed on EPS by $0.0 which was followed by a 6.75% increase in the share price the next day.

Here's a look at ADMA Biologics's past performance:

Quarter	Q4 2022	Q3 2022	Q2 2022	Q1 2022
EPS Estimate	-0.06	-0.08	-0.08	-0.08
EPS Actual	-0.06	-0.08	-0.07	-0.10
Revenue Estimate	45.93M	34.48M	31.81M	27.69M
Revenue Actual	49.98M	41.09M	33.91M	29.10M

To track all earnings releases for ADMA Biologics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Calendar